TY - JOUR
T1 - International consensus diagnostic criteria for autoimmune pancreatitis
T2 - Guidelines of the international association of pancreatology
AU - Shimosegawa, Tooru
AU - Chari, Suresh T.
AU - Frulloni, Luca
AU - Kamisawa, Terumi
AU - Kawa, Shigeyuki
AU - Mino-Kenudson, Mari
AU - Kim, Myung Hwan
AU - Klöppel, Günter
AU - Lerch, Markus M.
AU - Löhr, Matthias
AU - Notohara, Kenji
AU - Okazaki, Kazuichi
AU - Schneider, Alexander
AU - Zhang, Lizhi
PY - 2011/4
Y1 - 2011/4
N2 - OBJECTIVES: To achieve the goal of developing international consensus diagnostic criteria (ICDC) for autoimmune pancreatitis (AIP). METHODS: An international panel of experts met during the 14th Congress of the International Association of Pancreatology held in Fukuoka, Japan, from July 11 through 13, 2010. The proposed criteria represent a consensus opinion of the working group. RESULTS: Autoimmune pancreatitis was classified into types 1 and 2. The ICDC used 5 cardinal features of AIP, namely, imaging of pancreatic parenchyma and duct, serology, other organ involvement, pancreatic histology, and an optional criterion of response to steroid therapy. Each feature was categorized as level 1 and 2 findings depending on the diagnostic reliability. The diagnosis of type 1 and type 2 AIP can be definitive or probable, and in some cases, the distinction between the subtypes may not be possible (AIP-not otherwise specified). CONCLUSIONS: The ICDC for AIP were developed based on the agreement of an international panel of experts in the hope that they will promote worldwide recognition of AIP. The categorization of AIP into types 1 and 2 should be helpful for further clarification of the clinical features, pathogenesis, and natural history of these diseases.
AB - OBJECTIVES: To achieve the goal of developing international consensus diagnostic criteria (ICDC) for autoimmune pancreatitis (AIP). METHODS: An international panel of experts met during the 14th Congress of the International Association of Pancreatology held in Fukuoka, Japan, from July 11 through 13, 2010. The proposed criteria represent a consensus opinion of the working group. RESULTS: Autoimmune pancreatitis was classified into types 1 and 2. The ICDC used 5 cardinal features of AIP, namely, imaging of pancreatic parenchyma and duct, serology, other organ involvement, pancreatic histology, and an optional criterion of response to steroid therapy. Each feature was categorized as level 1 and 2 findings depending on the diagnostic reliability. The diagnosis of type 1 and type 2 AIP can be definitive or probable, and in some cases, the distinction between the subtypes may not be possible (AIP-not otherwise specified). CONCLUSIONS: The ICDC for AIP were developed based on the agreement of an international panel of experts in the hope that they will promote worldwide recognition of AIP. The categorization of AIP into types 1 and 2 should be helpful for further clarification of the clinical features, pathogenesis, and natural history of these diseases.
KW - autoimmune pancreatitis
KW - international consensus diagnostic criteria
KW - type 1 AIP
KW - type 2 AIP
UR - http://www.scopus.com/inward/record.url?scp=79953899882&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953899882&partnerID=8YFLogxK
U2 - 10.1097/MPA.0b013e3182142fd2
DO - 10.1097/MPA.0b013e3182142fd2
M3 - Article
C2 - 21412117
AN - SCOPUS:79953899882
SN - 0885-3177
VL - 40
SP - 352
EP - 358
JO - Pancreas
JF - Pancreas
IS - 3
ER -